COVID-19: Vaccines and Therapeutics

As summer moves along, the U.S. is marking a pivotal point in the pandemic. A majority of Americans 鈥 nearly 55% 鈥 now have received one COVID-19 vaccine dose, and 48% are fully vaccinated. 
鈥疞ifePoint Health combines the best of large health system resources and grassroots efforts to vaccinate hundreds of thousands of individuals across its national network.
Protecting community members by mitigating the spread of infection and feeling safe in the community were Faye Sheppard鈥檚 #MyWhy. Sheppard, a member of the American Society for Health Care Risk Management, an affiliate of the AHA, and vice chair of the Board of Directors for Cuero (Texas) Regional鈥
Pfizer Inc. will soon seek authorization for a booster dose of its COVID-19 vaccine, the company said, in an attempt to 鈥渟tay ahead鈥 of the coronavirus and its various mutations
The Commonwealth Fund reported that approximately 279,000 lives have been saved through the U.S.鈥檚 vaccination efforts, with 1.25 million avoiding hospitalization.
The Food and Drug Administration July 2 authorized for emergency use one more batch of drug substance for the Janssen (Johnson & Johnson) COVID-19 vaccine at an Emergent BioSolutions facility in Baltimore.
The White House plans to deploy COVID-19 surge response teams to help communities experiencing or at risk for hotspots due to the Delta variant and low vaccination with vaccination, testing, contact tracing, therapeutics and staffing, White House COVID-19 Response Coordinator Jeff Zients announced.
See who showed up to get their free Covid shot at our first pop-up clinic! It was great to watch folks go from nervous to relieved and excited. Mark your calendar for the next clinic on June 15. We have to protect people of color and that means getting vaccinated. Believe it! pic.twitter.com/鈥